We show that NFKBIE mutations contribute to disease progression by increasing the growth rate of CLL cells stimulated with microenvironmental signals that activate NF-κB and by inducing alterations within the tumor microenvironment that can allow for immune evasion of the malignant B-cells. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.